Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-09T01:32:27.339Z Has data issue: false hasContentIssue false
  • English
  • Français

Translating Evidence Into Practice: The Importance of Continuing Local Bacterial Surveillance Even When National Data Are Available

Published online by Cambridge University Press:  02 January 2015

Martin Darveau ,
Catherine Ducharme-Désilets ,
Patrick Archambault  and
Diane Marcoux
Martin Darveau*
Affiliation:
Pharmacy Department, Québec, Canada Centre Hospitalier Universitaire Affilié Hôtel-Dieu de Lévis, the Centre de recherche, Centre Hospitalier Affilié Universitaire de Québec, Québec, Canada
Catherine Ducharme-Désilets
Affiliation:
Faculty of Pharmacy, Université Laval, Québec, Canada
Patrick Archambault
Affiliation:
Department of Anesthesia and Emergency Medicine and Unité de recherche en médecine d'urgence, Québec, Canada Centre Hospitalier Universitaire Affilié Hôtel-Dieu de Lévis, the Centre de recherche, Centre Hospitalier Affilié Universitaire de Québec, Québec, Canada
Diane Marcoux
Affiliation:
Department of Microbiology, Québec, Canada
*
Pharmacy Department, Centre Hospitalier Universitaire Affilié Hôtel–Dieu de Lévis, 143 rue Wolfe, Lévis, Québec G6V 3Z1, Canada (martin_darveau@ssss.gouv.qc.ca)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 11 , November 2009 , pp. 1128 - 1130
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

References

1.Kollef, MH. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit Care 2005;9:459–464.CrossRefGoogle ScholarPubMed
2.Garnacho-Montero, J, Ortiz-Leyba, C, Herrera-Melero, I, et al.Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 2008;61:436–441.Google Scholar
3.Leone, M, Bourgoin, A, Cambon, S, Dubuc, M, Albanese, J, Martin, C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003;31(2):462–467.CrossRefGoogle ScholarPubMed
4.Kumar, A, Roberts, D, Wood, KE, et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–1596.CrossRefGoogle ScholarPubMed
5.Zhanel, GG, DeCorby, M, Laing, N, et al.Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006. Antimicrob Agents Chemother 2008;52:1430–1437.CrossRefGoogle ScholarPubMed
6.Masterton, R. The importance and future of antimicrobial surveillance studies. Clin Infect Dis 2008;47(Suppl 1):S21–S31.CrossRefGoogle ScholarPubMed
7.Graham, ID, Tetroe, J. Some theoretical underpinnings of knowledge translation. Acad Emerg Med 2007;14:936–941.CrossRefGoogle ScholarPubMed
8.Pagani, L, Falciani, M, Aschbacher, R. Use of microbiologic findings to manage antimicrobials in the intensive care unit. Infect Control Hosp Epidemiol 2009;30:309–311.CrossRefGoogle ScholarPubMed